AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Mglid GP 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Monsut Chem Industries

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Mglid GP 1mg/500mg Tablet SR

Glycipan SR tablets (1mg/500mg) are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Glycipan SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication is a component of a comprehensive diabetes management plan, encompassing dietary adjustments, physical activity, and weight management as recommended by your doctor. Lifestyle factors significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Mglid GP 1mg/500mg Tablet SR

No text provided to rephrase.

Uses of Mglid GP 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Mglid GP 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mglid GP 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Mglid GP 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Mglid GP 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Mglid GP 1mg/500mg Extended-Release tablets with food.

How Mglid GP 1mg/500mg Tablet SR works:

Mglid GP SR tablets (1mg/500mg) contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Mglid GP 1mg/500mg Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Mglid GP 1mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Mglid GP 1mg/500mg tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Mglid GP 1mg/500mg SR tablets; dosage modification may be necessary. Physician consultation is advised. The use of Mglid GP 1mg/500mg SR tablets is contraindicated in patients experiencing severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Mglid GP 1mg/500mg Tablet SR cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should begin with a low dose; however, this medication is contraindicated in those with severe liver disease. A physician's consultation is advised.

What if you forget to take Mglid GP 1mg/500mg Tablet SR :

Should you forget a Mglid GP 1mg/500mg Tablet SR, take it immediately upon remembering. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Mglid GP 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Mglid GP 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Mglid GP 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Mglid GP 1mg/500mg Tablet SR and seek immediate medical attention.
Mglid GP 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Mglid GP 1mg/500mg Tablet SR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Mglid GP 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Mglid GP 1mg/500mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Mglid GP 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Mglid GP 1mg/500mg Tablet...
94
MRP 108
13% off